Nordson (NDSN) Keeps 'Outperform' Rating with Raised Price Target to $275.00

Oppenheimer analyst Christopher Glynn maintains an "Outperform" rating for Nordson, raising the price target from $260 to $275. This change reflects a positive outlook for Nordson, as the company continues to maintain its status in the market. Analysts have made several adjustments in ratings and price targets for Nordson in the past, indicating a continued optimistic outlook for the company.

Title: Oppenheimer Analyst Upgrades Nordson's Rating and Price Target

Oppenheimer analyst Christopher Glynn has maintained an "Outperform" rating for Nordson Corporation (NDSN) while raising the price target from $260 to $275. This positive adjustment reflects a continued optimistic outlook for the company, as analysts have been making similar revisions to their ratings and price targets for Nordson in recent months [1].

Nordson, a leading manufacturer of equipment used for dispensing adhesives, coatings, and other materials, has demonstrated robust financial performance. The company reported a 12% year-over-year revenue increase to $742 million and adjusted earnings per share (EPS) rising 13% to $2.73 in the third quarter of 2025 [2]. The Advanced Technology Solutions (ATS) segment played a pivotal role in this success, delivering 17% sales growth, while the Medical and Fluid Solutions (MFS) segment saw a 32% revenue jump, primarily due to the Atrion acquisition [2].

Analysts have been increasingly confident in Nordson's future prospects, as evidenced by the upward trend in price targets. The average target price from 10 analysts is $253.53, with an average brokerage recommendation of "Outperform" [3]. Keybanc analyst Jeffrey Hammond, for instance, maintained an Overweight rating and increased the price target from $230 to $250, while Oppenheimer analyst Christopher Glynn upgraded the stock from Perform to Outperform with a price target of $260 [2].

Despite the positive outlook, Nordson faces some operational challenges. The company's net margin of 16.46% exceeds industry benchmarks, but its Return on Equity (ROE) and Return on Assets (ROA) lag behind industry averages. Additionally, Nordson's debt-to-equity ratio of 0.78 surpasses industry norms, indicating a substantial amount of debt that could pose financial challenges [3].

In conclusion, Oppenheimer analyst Christopher Glynn's price target increase reflects a cautious but optimistic view of Nordson's performance. The company's strong financial performance and analysts' ratings suggest a positive outlook for Nordson. However, investors should be mindful of the company's debt levels and operational challenges.

References:
1. [https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3UH0EY:0-amgen-figma-nordson/](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3UH0EY:0-amgen-figma-nordson/)
2. [https://www.gurufocus.com/news/3073897/nordson-corporation-ndsn-surpasses-q3-earnings-expectations-with-strong-growth](https://www.gurufocus.com/news/3073897/nordson-corporation-ndsn-surpasses-q3-earnings-expectations-with-strong-growth)
3. [https://www.ainvest.com/news/nordson-price-target-raised-252-neutral-rating-maintained-baird-analyst-2508/](https://www.ainvest.com/news/nordson-price-target-raised-252-neutral-rating-maintained-baird-analyst-2508/)